Standout Papers

Antithrombotic Therapy for VTE Disease 2008 2026 2014 2020 4.4k
  1. Antithrombotic Therapy for VTE Disease (2012)
    Clive Kearon, Elie A. Akl et al. CHEST Journal
  2. Pharmacology and Management of the Vitamin K Antagonists (2008)
    Jack Ansell, Jack Hirsh et al. CHEST Journal
  3. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia (2011)
    Cindy Neunert, Wendy Lim et al. Blood
  4. Executive Summary (2012)
    Gordon Guyatt, Elie A. Akl et al. CHEST Journal
  5. Oral Anticoagulant Therapy (2012)
    Walter Ageno, Alexander Gallus et al. CHEST Journal
  6. Evidence-Based Management of Anticoagulant Therapy (2012)
    Anne Holbrook, Sam Schulman et al. CHEST Journal
  7. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity (2015)
    Deborah Siegal, John T. Curnutte et al. New England Journal of Medicine
  8. Treatment and Prevention of Heparin-Induced Thrombocytopenia (2012)
    Lori‐Ann Linkins, Antonio L. Dans et al. CHEST Journal
  9. A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome (2003)
    Mark Crowther, Jeff Ginsberg et al. New England Journal of Medicine
  10. Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism (2003)
    Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine
  11. Acute Kidney Injury After Cardiac Surgery (2009)
    Keyvan Karkouti, Duminda N. Wijeysundera et al. Circulation
  12. Antiphospholipid syndrome (2010)
    Guillermo Ruiz‐Irastorza, Mark Crowther et al. The Lancet
  13. Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection (2016)
    Christine H. Lee, Theodore S. Steiner et al. JAMA
  14. Diagnosis of DVT (2012)
    Shannon M. Bates, Roman Jaeschke et al. CHEST Journal
  15. Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants (2014)
    Adam Cuker, Deborah Siegal et al. Journal of the American College of Cardiology
  16. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy (2018)
    Daniel M. Witt, Robby Nieuwlaat et al. Blood Advances
  17. Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum (2019)
    Adam Cuker, Allison Burnett et al. American Journal of Hematology

Immediate Impact

156 standout
Sub-graph 1 of 17

Citing Papers

Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
2023 Standout
Venous thromboembolism
2021 Standout
137 intermediate papers

Works of Mark Crowther being referenced

Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis
2017
Diagnosis of DVT
2012 Standout
and 83 more

Author Peers

Author Last Decade Papers Cites
Mark Crowther 20658 19077 9022 9917 573 38.6k
Jack Hirsh 22053 22531 8190 13188 345 37.9k
Sam Schulman 20968 21025 7556 6907 494 33.5k
Harry R. Büller 25437 19612 8368 8660 454 36.4k
Jeffrey I. Weitz 20237 22831 9016 8630 517 40.1k
Clive Kearon 26732 19932 5798 9538 227 33.5k
John A. Heit 22992 14795 6328 9054 214 30.0k
Michael Gent 16802 20314 5160 9176 229 35.3k
Samuel Z. Goldhaber 33904 26864 5294 10306 598 45.9k
Martin H. Prins 19486 17339 6708 8610 381 33.8k
Frits R. Rosendaal 15367 11047 18600 6410 803 40.2k

All Works

Loading papers...

Rankless by CCL
2026